Company / Cost of Revenue
CorVel Corporation Cost of Revenue History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$685.9M
FY2024
5-year range
$494.1M / $685.9M
FY2020-FY2024
Trend
+10.0%
vs FY2023
Sector context
#54 of 107
Health Care
What the data says
At $686M, CorVel Corporation's cost of revenue ranks #54 of 107 in the Health Care sector. Cost of Revenue has increased for 4 consecutive years, from $429M in FY2020 to $686M in FY2024.
Based on SEC 10-K filings.
$686M in FY2024 with a 5-year CAGR of +8.0%.
Increased from $560M to $686M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +11.5%
- 5-Year CAGR
- +8.0%
- 10-Year CAGR
- -
Sector benchmark
#54 of 107 in Health CareTop 50% of 107This company $685.9M Sector average $11.8B
▼
-94.2% below sector average
Key checks
Key Insights
- CorVel Corporation's cost of revenue has grown for 4 consecutive years.
- 5-year CAGR of +8.0%, indicating consistent growth.
- In FY2024, cost of revenue increased 10.0% year-over-year.
- Ranks #54 out of 107 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $685.9M | +10.0% |
| FY2023 | $623.6M | +11.3% |
| FY2022 | $560.3M | +13.4% |
| FY2021 | $494.1M | +15.2% |
| FY2020 | $429.0M | -8.0% |
| FY2019 | $466.3M | -1.0% |
| FY2018 | $470.9M | +4.4% |
| FY2017 | $451.1M | +9.0% |
| FY2016 | $413.9M | +3.7% |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026